Financials
- Financial year
- 2025
- Total assets
- €16.0m
- Loss
- -€13.4m
- Solvency
- 98.8%
Total assets▼ 48.5%
Net result
20202025
FLAMINGO THERAPEUTICS
InactiveOverview
Activity
“Het ontwerp,de ontwikkeling,de industrialisering en de commercialisering van therapeutische agenten,voor de behandeling van ziektes.” (deed in Dutch)
From the articles, 4 activitiesNo NACE code in the KBO yet
Size
€16.0mtotal assets 2025
- Staff
- 7.7 FTE
- Equity
- €15.8m
- Loss
- -€13.4m
Financial health
Inactive: no score
Structure
- Board
- 9 members
- Holdings
- 1
- Christopher MirabelliChair
- Toulon BVCEO · permanent representative Stéphane van Rooijen
Auditor: BDO Audit Sud & Est11 of 21 deeds summarised
Signalsraises riskPersistent lossesneutralLatest accounts filed on timeShow the evidence
Signals
Two signals.
raises riskneutral
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
202122232425
2020 to 2025 · latest year -€13.4m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-01-2026, 200 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
200 days early
2024
17 days early
2023
22 days early
2022
35 days early
2021
52 days early
2020
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 6 accounts on average 49 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
- Resignations & appointments · End &…Dissolution · Liquidation rule ·…
- Annual accounts filedfinancial year 2025 · full…
- Weakest financial yearnet -€13.4m
Key points
By topic
Board & ownership
- Board
- 9 members
- Auditor
- BDO Audit Sud &…
- Christopher MirabelliChair
- Biotech Fonds VlaanderenDirector
- BPIFRANCE INVESTISSEMENT SASDirector
- Brett Paul MoniaDirector
- Georges GemayelDirector
and 4 other directors
Network & group
- Subsidiaries
- 1
- Connected companies
- 1
- Mergers and asset contributions
- 1
1 subsidiary
Timeline
- Events
- 20
- Since
- 2021
- 14-07-2025Annual accounts filed
- 09-07-2024Annual accounts filed
- 03-07-2024Capital & shares · Amendment of the…
Company details
- Year ends
- 31-12
- Peppol
- Still in the Peppol directory
Articles of association
- Provisions read
- 41
- Who signs
- Two directors jointly
- Purpose
- “Het ontwerp,de ontwikkeling,de industrialisering en de commercialisering van…” (deed in Dutch)
Key facts about FLAMINGO THERAPEUTICS
- What is the company number of FLAMINGO THERAPEUTICS?
- 0729.892.237. In Belgium the VAT number is the company number with BE in front: BE 0729.892.237.
- What is the legal form of FLAMINGO THERAPEUTICS?
- BV.
- Is FLAMINGO THERAPEUTICS still active?
- No. FLAMINGO THERAPEUTICS is inactive in the KBO register.Company details
- How many employees did FLAMINGO THERAPEUTICS have?
- On average 7.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of FLAMINGO THERAPEUTICS?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
- Is FLAMINGO THERAPEUTICS profitable?
- In financial year 2025, FLAMINGO THERAPEUTICS made a loss of €13.4m.
- Where can I find the annual accounts of FLAMINGO THERAPEUTICS?
- FLAMINGO THERAPEUTICS filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
Go further with this company
What became of the directors' other companies?Supplier due diligence Who ran this company, and where was it based, on a given date before it ended?Company as of a date How is this company connected to another party?Network investigator
Investigating this company? Keep it with today's facts in a case file.